[144] United States Cellular Corporation 5.500% Senior Notes due 2070 SEC Filing
United States Cellular (symbol provided as UZE in metadata) filed a Form 144 disclosing a proposed sale of 35,724 common shares with an aggregate market value of $2,740,084.39. The sale is listed with Morgan Stanley Smith Barney LLC, Executive Financial Services and is scheduled on the NYSE for 08/12/2025. The filing shows the shares to be sold were mainly issued to the insider through restricted stock vesting under a registered plan on 04/05/2024 (34,055 shares) and 01/04/2024 (923 and 746 shares), with payment described as Services Rendered. The filer reports Nothing to Report for securities sold in the past three months and includes the standard representation that no undisclosed material adverse information is known.
United States Cellular (simbolo indicato come UZE nei metadati) ha depositato un Form 144 che segnala la proposta vendita di 35,724 azioni ordinarie per un valore di mercato complessivo di $2,740,084.39. La vendita risulta registrata con Morgan Stanley Smith Barney LLC, Executive Financial Services ed è prevista sul NYSE per il 08/12/2025. Il deposito indica che le azioni da vendere sono state principalmente assegnate all'insider tramite vesting di restricted stock nell'ambito di un piano registrato il 04/05/2024 (34,055 azioni) e il 01/04/2024 (923 e 746 azioni), con pagamento descritto come Services Rendered. Il dichiarante riporta Nothing to Report per titoli venduti negli ultimi tre mesi e include la consueta dichiarazione di non essere a conoscenza di informazioni materiali avverse non divulgate.
United States Cellular (símbolo indicado como UZE en los metadatos) presentó un Form 144 que revela una propuesta de venta de 35,724 acciones ordinarias por un valor de mercado agregado de $2,740,084.39. La operación figura con Morgan Stanley Smith Barney LLC, Executive Financial Services y está programada en la NYSE para el 08/12/2025. La presentación muestra que las acciones a vender se emitieron principalmente al insider mediante el vesting de restricted stock bajo un plan registrado el 04/05/2024 (34,055 acciones) y el 01/04/2024 (923 y 746 acciones), con el pago descrito como Services Rendered. El declarante informa Nothing to Report respecto a valores vendidos en los últimos tres meses e incluye la declaración estándar de no conocer información adversa material no divulgada.
United States Cellular(메타데이터에 심볼 UZE로 표기)는 Form 144를 제출해 총 시장가치 $2,740,084.39에 해당하는 35,724 보통주 매각 예정 사실을 공개했습니다. 해당 매각은 Morgan Stanley Smith Barney LLC, Executive Financial Services에 등재되어 있으며 NYSE에서 08/12/2025에 예정되어 있습니다. 제출서류에 따르면 매각 대상 주식은 주로 등록된 플랜에 따른 제한주식의 베스팅으로 내부자에게 발행된 것으로 04/05/2024(34,055주) 및 01/04/2024(923주 및 746주)에 부여되었고, 대금은 Services Rendered로 기재되어 있습니다. 제출자는 지난 3개월 동안 매도된 증권에 대해 Nothing to Report를 보고하며, 공개되지 않은 중대한 불리한 정보가 없음을 밝히는 표준 진술을 포함하고 있습니다.
United States Cellular (symbole indiqué UZE dans les métadonnées) a déposé un Form 144 révélant une proposition de vente de 35,724 actions ordinaires pour une valeur de marché totale de $2,740,084.39. La vente est enregistrée auprès de Morgan Stanley Smith Barney LLC, Executive Financial Services et est prévue à la NYSE pour le 08/12/2025. Le dossier indique que les actions à vendre ont été principalement attribuées à l'initié via le vesting de restricted stock dans le cadre d’un plan enregistré le 04/05/2024 (34,055 actions) et le 01/04/2024 (923 et 746 actions), le paiement étant décrit comme Services Rendered. Le déclarant signale Nothing to Report pour les titres vendus au cours des trois derniers mois et inclut la déclaration standard selon laquelle il n'a connaissance d'aucune information défavorable matérielle non divulguée.
United States Cellular (als Symbol in den Metadaten UZE angegeben) hat ein Form 144 eingereicht, das einen geplanten Verkauf von 35,724 Stammaktien mit einem aggregierten Marktwert von $2,740,084.39 offenlegt. Der Verkauf ist mit Morgan Stanley Smith Barney LLC, Executive Financial Services verzeichnet und für den 08/12/2025 an der NYSE terminiert. Die Einreichung zeigt, dass die zu veräußernden Aktien überwiegend dem Insider durch Vesting von Restricted Stock im Rahmen eines registrierten Plans am 04/05/2024 (34,055 Aktien) und am 01/04/2024 (923 und 746 Aktien) zugeteilt wurden; die Gegenleistung ist als Services Rendered angegeben. Der Meldende gibt für in den letzten drei Monaten verkaufte Wertpapiere Nothing to Report an und fügt die übliche Erklärung bei, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen bekannt sind.
- Transparent disclosure of proposed sale including broker, exchange, share count, and aggregate market value
- Securities originate from restricted stock vesting under a registered plan, indicating compensation-related disposition rather than market-driven sale
- None.
Insights
TL;DR: Small issuer insider sale filed under Rule 144; transaction appears routine and disclosed through a major broker.
The filing documents a proposed sale of 35,724 common shares valued at approximately $2.74 million, executed through Morgan Stanley Smith Barney on the NYSE. Shares originated from restricted stock vesting as compensation, which is typical for insider dispositions once transfer restrictions lapse. No prior disposals in the past three months are reported, reducing concerns about rapid insider unloading. Given disclosed source and broker handling, this appears to be a routine, compliance-focused disclosure rather than a material corporate development.
TL;DR: The Form 144 provides transparent disclosure of compensation-related share vesting and an intended sale; governance procedures appear followed.
The filing identifies the shares as coming from restricted stock vesting under a registered plan and documents the representative certification regarding undisclosed material information. Use of a national broker and explicit listing of shares outstanding and aggregate market value align with required transparency. Absence of recent disposals and the inclusion of standard signature/representation language suggest adherence to regulatory and governance expectations for insider trading disclosures.
United States Cellular (simbolo indicato come UZE nei metadati) ha depositato un Form 144 che segnala la proposta vendita di 35,724 azioni ordinarie per un valore di mercato complessivo di $2,740,084.39. La vendita risulta registrata con Morgan Stanley Smith Barney LLC, Executive Financial Services ed è prevista sul NYSE per il 08/12/2025. Il deposito indica che le azioni da vendere sono state principalmente assegnate all'insider tramite vesting di restricted stock nell'ambito di un piano registrato il 04/05/2024 (34,055 azioni) e il 01/04/2024 (923 e 746 azioni), con pagamento descritto come Services Rendered. Il dichiarante riporta Nothing to Report per titoli venduti negli ultimi tre mesi e include la consueta dichiarazione di non essere a conoscenza di informazioni materiali avverse non divulgate.
United States Cellular (símbolo indicado como UZE en los metadatos) presentó un Form 144 que revela una propuesta de venta de 35,724 acciones ordinarias por un valor de mercado agregado de $2,740,084.39. La operación figura con Morgan Stanley Smith Barney LLC, Executive Financial Services y está programada en la NYSE para el 08/12/2025. La presentación muestra que las acciones a vender se emitieron principalmente al insider mediante el vesting de restricted stock bajo un plan registrado el 04/05/2024 (34,055 acciones) y el 01/04/2024 (923 y 746 acciones), con el pago descrito como Services Rendered. El declarante informa Nothing to Report respecto a valores vendidos en los últimos tres meses e incluye la declaración estándar de no conocer información adversa material no divulgada.
United States Cellular(메타데이터에 심볼 UZE로 표기)는 Form 144를 제출해 총 시장가치 $2,740,084.39에 해당하는 35,724 보통주 매각 예정 사실을 공개했습니다. 해당 매각은 Morgan Stanley Smith Barney LLC, Executive Financial Services에 등재되어 있으며 NYSE에서 08/12/2025에 예정되어 있습니다. 제출서류에 따르면 매각 대상 주식은 주로 등록된 플랜에 따른 제한주식의 베스팅으로 내부자에게 발행된 것으로 04/05/2024(34,055주) 및 01/04/2024(923주 및 746주)에 부여되었고, 대금은 Services Rendered로 기재되어 있습니다. 제출자는 지난 3개월 동안 매도된 증권에 대해 Nothing to Report를 보고하며, 공개되지 않은 중대한 불리한 정보가 없음을 밝히는 표준 진술을 포함하고 있습니다.
United States Cellular (symbole indiqué UZE dans les métadonnées) a déposé un Form 144 révélant une proposition de vente de 35,724 actions ordinaires pour une valeur de marché totale de $2,740,084.39. La vente est enregistrée auprès de Morgan Stanley Smith Barney LLC, Executive Financial Services et est prévue à la NYSE pour le 08/12/2025. Le dossier indique que les actions à vendre ont été principalement attribuées à l'initié via le vesting de restricted stock dans le cadre d’un plan enregistré le 04/05/2024 (34,055 actions) et le 01/04/2024 (923 et 746 actions), le paiement étant décrit comme Services Rendered. Le déclarant signale Nothing to Report pour les titres vendus au cours des trois derniers mois et inclut la déclaration standard selon laquelle il n'a connaissance d'aucune information défavorable matérielle non divulguée.
United States Cellular (als Symbol in den Metadaten UZE angegeben) hat ein Form 144 eingereicht, das einen geplanten Verkauf von 35,724 Stammaktien mit einem aggregierten Marktwert von $2,740,084.39 offenlegt. Der Verkauf ist mit Morgan Stanley Smith Barney LLC, Executive Financial Services verzeichnet und für den 08/12/2025 an der NYSE terminiert. Die Einreichung zeigt, dass die zu veräußernden Aktien überwiegend dem Insider durch Vesting von Restricted Stock im Rahmen eines registrierten Plans am 04/05/2024 (34,055 Aktien) und am 01/04/2024 (923 und 746 Aktien) zugeteilt wurden; die Gegenleistung ist als Services Rendered angegeben. Der Meldende gibt für in den letzten drei Monaten verkaufte Wertpapiere Nothing to Report an und fügt die übliche Erklärung bei, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen bekannt sind.
FAQ
What does the UZE Form 144 disclose?
Where did the shares being sold come from according to the filing?
Does the filing report any other securities sold in the past three months?
Which broker is handling the proposed sale in the Form 144?
Does the filer assert knowledge of undisclosed material information?
